Načítá se...

The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates

CA 19-9 and CEA are the most commonly used biomarkers for diagnosis and management of patients with pancreatic cancer. Since the original compendium by Steinberg in 1990, numerous studies have reported the use of CA 19-9 and, to a lesser extent, CEA in the diagnosis of pancreatic cancer. Here we upd...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Mol Med
Hlavní autoři: Poruk, Katherine E., Gay, David Z., Brown, Kurt, Mulvihill, Jeffrey D., Boucher, Kenneth M., Scaife, Courtney L., Firpo, Matthew A., Mulvihill, Sean J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419808/
https://ncbi.nlm.nih.gov/pubmed/23331006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!